Skip to content (Press Enter)

Elke.Rink@nuigalway.ie +353 (0)91 495244

PMSMatTrain: Novel Biomaterial-based Device for the Treatment of Progressive MS

Home
About Us
More Information
Events
News
Contact

Post Three

BY wwmDecember 12, 2016

In enim justo, rhoncus ut, imperdiet venenatis vitae, justo.

Post navigation

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search

Search for:

Social Media

Follow us on Facebook

Tweets by PMSMatTrain

pmsmattrain

NAME: Elif Nur Yılmaz HOMETOWN: Istanbul, Turkey

NAME: Elif Nur Yılmaz

HOMETOWN: Istanbul, Turkey

CURRENTLY IN: Münster, Germany

Elif Nur Yilmaz obtained her BSc in Molecular Biology and Genetics at Yildiz Technical University, Turkey and her MSc in Biomedical Engineering and Bioinformatics at Istanbul Medipol University, Turkey. Her research focus is to develop and validate the therapeutic efficacy of a novel device housing a multi-modal hydrogel using iPSC derived in vitro models of multiple sclerosis. Within PMSMatTrain she is working under the supervision of Prof. Tanja Kuhlmann at the Institute of Neuropathology, University Hospital Münster, Germany (WWU).

NAME: Jack Hampson HOMETOWN: Manchester, Englan

NAME: Jack Hampson

HOMETOWN: Manchester, England

CURRENTLY IN: Galway, Ireland

Jack Hampson obtained a BSc. Hons with Applied Mathematics at NUI Galway, and MSc. in Aerospace Engineering at the University of Manchester. After university, he worked as a project engineer for a superconducting magnet manufacturer. However, after dissertations concerning ‘mechanics of growth’ and ‘aneurysm detection with ultrasound’, as well as working with MRI magnets, Jack chose to pursue a PhD through PMSMatTrain under Dr Nathan Quinlan. His research will be modelling a novel method of drug delivery targeting multiple sclerosis.

NAME: Daniela Costa aka Neuronika HOMETOWN: Coimb

NAME: Daniela Costa aka Neuronika

HOMETOWN: Coimbra, Portugal

CURRENTLY IN: Galway, Ireland

Daniela AD Costa graduated in Biochemistry and received an MSc in Cellular and Molecular Biology from the Univ. of Coimbra, Portugal. Later, she engaged in a Michael J. Fox Foundation-funded project at the Univ. of Bordeaux, France. As part of the EU ITN PMSMatTrain consortium, she is currently testing a therapeutic agent delivery system for Progressive Multiple Sclerosis, focusing on the vulnerable subpopulations of cortical neurons. Daniela will be carrying out her research under the supervision of Dr Una Fitzgerald and co-supervision of Dr Jill McMahon at National University Ireland Galway (NUIG), Ireland.

NAME: Małgorzata Dąbrowska HOMETOWN: Opole, Pol

NAME: Małgorzata Dąbrowska

HOMETOWN: Opole, Poland

CURRENTLY IN: Galway, Ireland

Małgorzata Dąbrowska received her MSc in Neuroscience at Jagiellonian Univ. Cracow, Poland. During her thesis, she worked on the impact of a KCNQ1 channel mutation associated with the Brugada Syndrome at the University of Antwerp, Belgium. Later, she worked at the Małopolskie Centre of Biotechnology in Cracow, Poland. Małgorzata has a deep passion for the neurodegenerative side of neuroscience, especially multiple sclerosis. She is working under supervision of Dr Una Fitzgerald at National University Ireland Galway (NUIG), Ireland in the PMSMatTrain project.

NAME: Yağmur Bozkurt aka “Sugar girl” HOMETO

NAME: Yağmur Bozkurt aka “Sugar girl”

HOMETOWN: Istanbul, Turkey

CURRENTLY IN: Galway, Ireland

Yağmur Bozkurt received her BSc degree in Genetics and Bioengineering and her MSc in Bioengineering in Yildiz Technical University in Istanbul. Her research topic focuses on investigating glycosylation patterns in primary multiple sclerosis, how these patterns are related to the disease pathology and their potential use as therapeutic targets for the treatment. Within PMSMatTrain, she is working under the supervision of Prof. Abhay Pandit at CÚRAM, National University Ireland Galway (NUIG), Ireland.

You can find us 👇 ☒ Facebook: @pmsmatrain ☒

You can find us 👇
☒ Facebook: @pmsmatrain
☒ Twitter: @PMSMatTrain
☒ Website: pmsmattrain.eu
☒ Email: pmsmattrain@gmail.com

Don't waste a bit. Let the games begin 📔🧪

Share some love and support us in our PhD journey!

Share some love and support us in our PhD journey! 🤓

Check out our social media!

Welcome to the #MSResearch World! Our fellows are

Welcome to the #MSResearch World! Our fellows are excited to guide you and demystify #science and #research about #MultipleSclerosis 🧫

Follow on Instagram

Project Manager

Dr Elke Rink
Biomedical Sciences,
National University of Ireland Galway,
Galway,
Ireland

(c) Copyright 2020 PMSMatTrain

Contact

Elke.Rink@nuigalway.ie
+353 (0)91 495244

Privacy & Cookies Policy

Privacy & Cookies Policy

© Copyright 2021 pmsmattrain. Rara Academic | Developed By Rara Theme. Powered by WordPress.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT Privacy & Cookies Policy

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT